Neuland Laboratories Limited (BOM:524558)
India · Delayed Price · Currency is INR 19,517
-3 (-0.01%)
At close: Jul 10, 2026
Neuland Laboratories Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Neuland Laboratories stock has a consensus rating of "Strong Buy" and an average price target of ₹20,972. The average 1-year stock price forecast is 7.46% higher than the current stock price, while the lowest is ₹19,550 (+0.17%) and the highest is ₹22,913 (+17.40%).
Price Target: ₹20,972 (+7.46%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Neuland Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
23.09B
from 20.23B
Increased by 14.13%
Revenue Next Year
27.80B
from 23.09B
Increased by 20.40%
EPS This Year
326.80
from 283.71
Increased by 15.19%
EPS Next Year
454.89
from 326.80
Increased by 39.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 23.6B | ||
| Avg | 23.1B | ||
| Low | 22.3B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 16.7% | ||
| Avg | 14.1% | ||
| Low | 10.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 345.30 | ||
| Avg | 326.80 | ||
| Low | 314.00 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 21.7% | ||
| Avg | 15.2% | ||
| Low | 10.7% |